These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7859796)

  • 1. No white matter abnormalities in untreated patients with persistent hyperphenylalaninaemia: findings in magnetic resonance imaging. German PKU Collaborative Study.
    Weglage J; Ullrich K; Schuierer G; Pietsch M; Fünders B
    Eur J Pediatr; 1994 Dec; 153(12):918-9. PubMed ID: 7859796
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.
    Bick U; Ullrich K; Stöber U; Möller H; Schuierer G; Ludolph AC; Oberwittler C; Weglage J; Wendel U
    Eur J Pediatr; 1993 Dec; 152(12):1012-20. PubMed ID: 8131802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP
    J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperphenylalaninemia: CT and MR of the brain.
    Brismar J; Aqeel A; Gascon G; Ozand P
    AJNR Am J Neuroradiol; 1990; 11(1):135-8. PubMed ID: 2105595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine.
    Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H
    Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.
    Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D
    Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging.
    Bick U; Fahrendorf G; Ludolph AC; Vassallo P; Weglage J; Ullrich K
    Eur J Pediatr; 1991 Jan; 150(3):185-9. PubMed ID: 2044589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J; Fätkenheuer B; Burgard P; Armbruster M; Esser G; Schmidt H
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.
    Leuzzi V; Trasimeni G; Gualdi GF; Antonozzi I
    J Inherit Metab Dis; 1995; 18(5):624-34. PubMed ID: 8598645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain CT and MR findings in hyperphenylalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria).
    Sugita R; Takahashi S; Ishii K; Matsumoto K; Ishibashi T; Sakamoto K; Narisawa K
    J Comput Assist Tomogr; 1990; 14(5):699-703. PubMed ID: 2398144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranial MR in phenylketonuria.
    Shaw DW; Weinberger E; Maravilla KR
    J Comput Assist Tomogr; 1990; 14(3):458-60. PubMed ID: 2335616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult phenylketonuria presenting with subacute severe neurologic symptoms.
    Seki M; Takizawa T; Suzuki S; Shimizu T; Shibata H; Ishii T; Hasegawa T; Suzuki N
    J Clin Neurosci; 2015 Aug; 22(8):1361-3. PubMed ID: 25913748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.